These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29425507)

  • 1. Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15.
    Jones JE; Cadena SM; Gong C; Wang X; Chen Z; Wang SX; Vickers C; Chen H; Lach-Trifilieff E; Hadcock JR; Glass DJ
    Cell Rep; 2018 Feb; 22(6):1522-1530. PubMed ID: 29425507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.
    Zimmers TA; Jiang Y; Wang M; Liang TW; Rupert JE; Au ED; Marino FE; Couch ME; Koniaris LG
    Basic Res Cardiol; 2017 Jul; 112(4):48. PubMed ID: 28647906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
    Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?
    Harper SC; Brack A; MacDonnell S; Franti M; Olwin BB; Bailey BA; Rudnicki MA; Houser SR
    Circ Res; 2016 Apr; 118(7):1143-50; discussion 1150. PubMed ID: 27034276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.
    Egerman MA; Glass DJ
    Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):174-183. PubMed ID: 31144559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.
    Rochette L; Zeller M; Cottin Y; Vergely C
    Pharmacol Ther; 2015 Dec; 156():26-33. PubMed ID: 26523637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
    Egerman MA; Cadena SM; Gilbert JA; Meyer A; Nelson HN; Swalley SE; Mallozzi C; Jacobi C; Jennings LL; Clay I; Laurent G; Ma S; Brachat S; Lach-Trifilieff E; Shavlakadze T; Trendelenburg AU; Brack AS; Glass DJ
    Cell Metab; 2015 Jul; 22(1):164-74. PubMed ID: 26001423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
    Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
    Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraphysiological levels of GDF11 induce striated muscle atrophy.
    Hammers DW; Merscham-Banda M; Hsiao JY; Engst S; Hartman JJ; Sweeney HL
    EMBO Mol Med; 2017 Apr; 9(4):531-544. PubMed ID: 28270449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DA-Raf and the MEK inhibitor trametinib reverse skeletal myocyte differentiation inhibition or muscle atrophy caused by myostatin and GDF11 through the non-Smad Ras-ERK pathway.
    Masuzawa R; Takahashi K; Takano K; Nishino I; Sakai T; Endo T
    J Biochem; 2022 Jan; 171(1):109-122. PubMed ID: 34676394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
    Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
    Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological levels of GDF11 activate Smad2/Smad3 signaling and induce muscle atrophy in human iPSC-derived myocytes.
    Honda M; Makino T; Zhao X; Matsuto M; Sakurai H; Takahashi Y; Shimizu M; Sato R; Yamauchi Y
    Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1402-C1409. PubMed ID: 36094432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundancy of myostatin and growth/differentiation factor 11 function.
    McPherron AC; Huynh TV; Lee SJ
    BMC Dev Biol; 2009 Mar; 9():24. PubMed ID: 19298661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.
    Lach-Trifilieff E; Minetti GC; Sheppard K; Ibebunjo C; Feige JN; Hartmann S; Brachat S; Rivet H; Koelbing C; Morvan F; Hatakeyama S; Glass DJ
    Mol Cell Biol; 2014 Feb; 34(4):606-18. PubMed ID: 24298022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain.
    Rodgers BD; Eldridge JA
    Endocrinology; 2015 Nov; 156(11):3885-8. PubMed ID: 26372181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death.
    Harper SC; Johnson J; Borghetti G; Zhao H; Wang T; Wallner M; Kubo H; Feldsott EA; Yang Y; Joo Y; Gou X; Sabri AK; Gupta P; Myzithras M; Khalil A; Franti M; Houser SR
    Circ Res; 2018 Nov; 123(11):1220-1231. PubMed ID: 30571461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
    Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF11 impairs liver regeneration in mice after partial hepatectomy.
    Wang W; Yang X; Yang J; Liu S; Lv Y; Zhang C; Dong W; Liu A
    Clin Sci (Lond); 2019 Oct; 133(20):2069-2084. PubMed ID: 31654062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease.
    Onodera K; Sugiura H; Yamada M; Koarai A; Fujino N; Yanagisawa S; Tanaka R; Numakura T; Togo S; Sato K; Kyogoku Y; Hashimoto Y; Okazaki T; Tamada T; Kobayashi S; Yanai M; Miura M; Hoshikawa Y; Okada Y; Suzuki S; Ichinose M
    Thorax; 2017 Oct; 72(10):893-904. PubMed ID: 28455454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for potency differences between GDF8 and GDF11.
    Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
    BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.